perkinelm revenu grew organ street
estim organ normal ep consensu
expect manag ep guidanc line street appear
conserv given myriad growth driver manag success pivot
compani higher mid-to-high singl digit growth environ rais
price target base ep estim
maintain ow rate share
result revenu grew organ street
organ discoveri analyt system da grew organ
report street diagnost grew organ
report street adj gross margin expand
street adj oper expens pjc
yield improv adj oper margin non-gaap ep
consensu favor tax rate larg offset addit
guidanc manag initi guidanc organ growth vs
consensu ep line street estim
call organ revenu growth vs street
guidanc shortfal larg time relat due govern shutdown
trickl throughout rest compani modestli bring
assumpt strong grower pharma industri environment larg
conservat view addit spoke deal activ well
buyback includ guidanc
busi updat quarter driven broad strength portfolio region
euroimmun solid though miss manag target actual
due pace expect one-tim order new product pois
contribut highlight vanadi nipt commerci track
larg expect system place vs guidanc increment pull
qsight recent cannabi test add-on
reiter overweight shift valuat methodolog rais
price target target base unchang
ep estim believ well posit keep deliv
upsid consensu expect reiter ow rate
competit emerg disrupt technolog execut new product launch
foreign currenc
develop manufactur sell product environment market
price close januari
forma ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
million
good sold
provis incom tax
good sold
research develop
compani report piper jaffray co up-to-d compani disclosur inform pleas visit http //www piperjaffray com/researchdisclosur
